Risk factors, management, and future fertility of empty follicle syndrome: a retrospective study with real-world data

被引:0
|
作者
Luo, Zhuoye [1 ,2 ,3 ,4 ]
Xu, Suxin [1 ,2 ,3 ,4 ]
Hao, Guimin [1 ,2 ,3 ,4 ]
机构
[1] Hebei Med Univ, Dept Reprod Med, Hosp 2, Shijiazhuang, Peoples R China
[2] Hebei Ctr Qual Control & Management Human Assisted, Shijiazhuang, Peoples R China
[3] Hebei Key Lab Infertil & Hered, Shijiazhuang, Peoples R China
[4] Hebei Clin Res Ctr Birth Defects, Shijiazhuang, Peoples R China
来源
关键词
empty follicle syndrome; oocyte trigger; hCG exposure time; polycystic ovary syndrome; cumulative live birth rate; IN-VIVO; MATURATION; HCG; INTERVAL; PREVALENCE; GENE;
D O I
10.3389/fendo.2024.1424837
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Empty follicle syndrome (EFS) is a challenging clinical problem. This study aims to identify the risk factors for EFS, to present pregnancy outcomes in both EFS cycle as well as subsequent cycles, and to summarize an effective rescue protocol to improve outcomes. Methods: A retrospective analysis between 2016 and 2020 was conducted at our center. Stricter criteria were applied to diagnose EFS. Logistic regression analysis was used to identify the risk factors for EFS. Further analyses were performed within the EFS cycle to present pregnancy outcomes and to find optimal rescue protocols. Long-term follow-up was conducted until live birth was achieved, covering at least two complete oocyte retrieval cycles. Results: Among 14,066 patients, 54 (0.38%) were identified as EFS. Patients with polycystic ovary syndrome (PCOS) had a significantly higher risk of developing EFS than non-PCOS ones (aOR = 2.67; 95% CI, 1.47 to 4.83). Within EFS patients, delaying the second oocyte retrieval by 3-6 h significantly improved the rates of obtaining oocyte (97.4% versus 58.3%, P = 0.002), getting embryo available for transfer (92.3% versus 33.3%, P < 0.001), and pregnancy (48.7% versus 8.3%, P = 0.017) compared to other delayed retrieval times. Overall, 31.5% (17/54) and 46.7% (7/15) EFS patients achieved live birth in the EFS cycle and the future cycle, respectively. Conclusions: PCOS is an independent risk factor for EFS, indicating that longer exposure time to human chorionic gonadotropin (hCG) may be necessary. Delaying the second oocyte retrieval by 3-6 h is an effective rescue protocol for EFS patients to achieve optimal outcomes. EFS in a single cycle does not necessarily indicate future fertility decline, but repeated EFS may result in poor outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] POTENTIALLY MODIFIABLE RISK FACTORS FOR ALZHEIMER DISEASE IN COLOMBIA: A REAL-WORLD DATA ANALYSIS
    Salazar-Londono, S.
    Herrera-Velez, L.
    Silva-Buritica, C.
    Rincon, C. J.
    Rosselli, D.
    VALUE IN HEALTH, 2024, 27 (06) : S358 - S359
  • [42] Real-world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study
    Kuehne, Fabienne
    Becker, Lena-Luise
    Bast, Thomas
    Bertsche, Astrid
    Borggraefe, Ingo
    Bosselmann, Christian Malte
    Fahrbach, Joerg
    Hertzberg, Christoph
    Herz, Nina A.
    Hirsch, Martin
    Holtkamp, Martin
    Janello, Christine
    Kluger, Gerhard Josef
    Kurlemann, Gerhard
    Lerche, Holger
    Makridis, Konstantin L.
    von Podewils, Felix
    Pringsheim, Milka
    Schubert-Bast, Susanne
    Schulz, Juliane
    Schulze-Bonhage, Andreas
    Steinbart, David
    Steinhoff, Bernhard J.
    Strzelczyk, Adam
    Syrbe, Steffen
    De Vries, Heike
    Wagner, Christiane
    Wagner, Johanna
    Wilken, Bernd
    Prager, Christine
    Klotz, Kerstin A.
    Kaindl, Angela M.
    EPILEPSIA OPEN, 2023, 8 (02) : 360 - 370
  • [43] The Role of Heterogenous Real-world Data for Dengue Surveillance in Martinique: Observational Retrospective Study
    Sylvestre, Emmanuelle
    Cecilia-Joseph, Elsa
    Bouzille, Guillaume
    Najioullah, Fatiha
    Etienne, Manuel
    Malouines, Fabrice
    Rosine, Jacques
    Julie, Sandrine
    Cabie, Andre
    Cuggia, Marc
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2022, 8 (12):
  • [44] Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study
    Gladstone, Jonathan
    Chhibber, Sameer
    Minhas, Jagdeep
    Neish, Calum S.
    Power, G. Sarah
    Lan, Zhiyi
    Rochdi, Driss
    Lanthier-Martel, Jessica
    Bastien, Natacha
    HEADACHE, 2022, 62 (01): : 78 - 88
  • [45] Incidence trends and risk factors for hyponatremia in epilepsy patients: A large-scale real-world data study
    Yamamoto, Yoshiaki
    Ohta, Akiko
    Usui, Naotaka
    Imai, Katsumi
    Kagawa, Yoshiyuki
    Takahashi, Yukitoshi
    HELIYON, 2023, 9 (08)
  • [46] Real-World Data on the Risk of Ventricular Arrhythmias with Sulfonamides
    Gerard, Alexandre O.
    Merino, Diane
    Drici, Milou-Daniel
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (02) : 201 - 202
  • [47] A Study of Real-World Data Races in Golang
    Chabbi, Milind
    Ramanathan, Murali Krishna
    PROCEEDINGS OF THE 43RD ACM SIGPLAN INTERNATIONAL CONFERENCE ON PROGRAMMING LANGUAGE DESIGN AND IMPLEMENTATION (PLDI '22), 2022, : 474 - 489
  • [48] MitraClip Real-World Data: What Is Missing and Looking Into the Future
    Mesana, Thierry G.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2020, 21 (09) : 1063 - 1064
  • [49] Risk factors for empty follicle syndrome in diminished ovarian reserve patients undergoing intracytoplasmic sperm injection cycles: A retrospective observational analysis
    Devranoglu, Belgin
    Yilmaz, Muserref Banu
    Peker, Gamze
    Ozay, Ozlen Emekci
    Ozay, Ali Cenk
    Guzel, Ali Irfan
    MEDICINE, 2024, 103 (28) : e38902
  • [50] Selinexor in Combination with Azacitidine ( AZA) in Patients with Myelodysplastic Syndrome (MDS): A Real-World Retrospective Study
    Zhou, Huifen
    Wu, Xiaoxia
    Yang, Zhen
    Zhang, Xinhui
    Lu, Shenqi
    Wu, Depei
    Miao, Miao
    BLOOD, 2023, 142